Jim Cramer on Merck, Healthcare Stocks, and AI in Drug Discovery

Healthcare Sector Outlook

• 💡 The JP Morgan Healthcare Conference is highlighted as a key event where announcements and deals are expected, potentially boosting the healthcare segment.
• 📈 Cramer anticipates the healthcare sector to be "on fire" leading up to the conference, with largely positive news flow.
• 🚀 Upgrades for companies like Merck are seen as a precursor to this positive trend.

Biotech and Venture Capital

• 🚀 Biotech experienced a significant surge in the last quarter of 2025, despite prior concerns about FDA approvals.
• ⚠️ There were earlier concerns about venture money not being as confident, but the sector still took off.

AI's Role in Drug Discovery

• 🧠 A major theme this year is expected to be AI and drug discovery.
• 💊 Jensen is cited as predicting that this year will see AI contribute to the development of new drugs.
• 💬 While AI has societal negatives, its potential in drug discovery is a significant positive counterpoint.
• 🧪 Despite the hope, some drug CEOs are struggling to make progress, making AI a crucial element for breakthroughs.

Stock Market Movers

• 📉 Merck shares are being closely watched, with a recent upgrade from "hold" to "buy" for a potential breakout.
• ⚠️ Other stocks like Western Dig, Dell, and AAT were lagging, indicating a "tech day" with a focus on "drug day".
• ❓ The reason for Nvidia not being up on this particular day is humorously attributed to Paramount.